Eleanor Health, the first addiction and mental health provider delivering comprehensive, whole-person care through population- and value-based payment models, today announced it has closed a $50M Series C financing led by General Catalyst. The Company received significant participation from existing investors including Warburg Pincus and Town Hall Ventures, as well as new participation from Northpond Ventures and Rethink Impact, a venture capital firm investing in tech-forward organizations with female and non-binary leaders.

Eleanor Health provides evidence-based, whole-person care specializing in addressing the unique complexities of individuals and populations with substance use disorders and mental health needs. Eleanor leverages proprietary technology and data-driven insights, compassionate teams, and population- and value-based payment to deliver superior clinical and financial outcomes.